Purchase this article with an account.
Walter I Rivera, Sarah E Miller, Rashed Alhabshan, Victor H Gonzalez; Choroidal Thickness in Central Serous Retinopathy in Patients with Active and Inactive Disease.. Invest. Ophthalmol. Vis. Sci. 2019;60(9):4328.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Little is known about the comparison of choroidal thickness between active and inactive disease status in patients with central serous chorioretinopathy (CSCR). Our objective is to report choroidal thickness measurements in patients with active and inactive central serous chorioretinopathy.
This retrospective cohort study included 44 eyes with a diagnosis of central serous chorioretinopathy. The cohort was divided into group A defined as patients who presented with the presence of subretinal fluid on swept-source optic coherence tomography (SS-OCT) (active disease) and group B defined as patients with a history of subretinal fluid without fluid currently seen on SS-OCT (inactive disease). Measurements for choroidal thickness were performed using SS-OCT (Carl Zeiss, Germany). Statistical analysis was conducted using R version 3.5.0.
The mean patient age was 58.8 years and 57.9 for group A and B respectively (ranges from 41-77 years). 22 eyes were included in the group A analysis. 22 eyes were included in the group B analysis. Group A had a mean visual acuity of 20/125. Group B had a mean visual acuity of 20/80 . Group A was found to have a mean choroidal thickness of 384.7 microns (95% CI: 348.4,421). Group B had a mean choroidal thickness of 377.2 microns (95% CI: 338.5,415.9)
Although there was a tendency toward less choroidal thickness in the inactive group versus those with active disease as defined in our study, there was no statistical difference in mean choroidal thickness between the groups.
This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.
This PDF is available to Subscribers Only